| Literature DB >> 34622970 |
Yaping Zhang1, Min Chen1, Yu Yu1, Xiaoyu Liu1, Weiping Liu1, Lijun Jiang2, Wenyan Zhang1.
Abstract
Primary cutaneous anaplastic large-cell lymphoma (pC-ALCL) is distinguished from systemic anaplastic large-cell lymphoma (S-ALCL) with cutaneous involvement. Although pC-ALCL is a unique entity with different genetics, clinical characteristics, and prognosis, its causes are unknown. Herein, we report the case of a Chinese woman with a 4-month history of a gradually enlarged ulcerative mass in her right forearm following an unidentified insect bite. Biopsy revealed an extensive infiltrate with patches of large anaplastic lymphoid cells. These cells were immunohistochemically positive for CD45, CD30, and TIA-1 and negative for CD2, CD3, CD4, CD5, CD20, CD7, CD8, and ALK-1. DUSP22-IRF4 rearrangement was detected; on the other hand, TP63 rearrangement was not observed by fluorescence in situ hybridization (FISH). No Epstein-Barr virus-encoded small RNAs (EBERs) were detected by ISH. Rearrangement of monoclonal TCR gene was found using BIOMED-2 polymerase chain reaction. No abnormality was found on the subsequent positron emission tomography-computed tomography (PET-CT) scan. After five cycles of cyclophosphamide + doxorubicin + vincristine + prednisolone (CHOP) chemotherapy, the patient achieved complete remission. This is the first report of a unique pC-ALCL with DUSP22-IRF4 rearrangement following an insect bite other than S-ALCL involving the skin.Entities:
Keywords: DUSP22-IRF4; anaplastic large-cell lymphoma; cutaneous; insect bite; primary
Mesh:
Substances:
Year: 2021 PMID: 34622970 PMCID: PMC9297975 DOI: 10.1111/cup.14147
Source DB: PubMed Journal: J Cutan Pathol ISSN: 0303-6987 Impact factor: 1.458
FIGURE 1Primary cutaneous anaplastic large‐cell lymphoma with DUSP22‐IRF4 rearrangement. Gross appearance of skin lesion (A). Medium‐to‐large distribution of the dysplastic lymphocytes in the dermis (B, H&E ×200). Abundant nucleoli and pathological mitotic image (C, H&E ×400). The cells were positive for CD45 (D, immunohistochemistry (IHC) ×400) and CD30 (E, IHC ×400). Fluorescent in situ hybridization shows DUSP22‐IRF4 gene rearrangement (F, fluorescence in situ hybridization)